J S Kalsi
Overview
Explore the profile of J S Kalsi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalsi H, Kalsi J, Fisher N
Br Dent J
. 2013 Nov;
215(10):519-24.
PMID: 24264671
Workplace-based assessments (WBAs) are trainee-led formative assessments that measure the highest level of competence of the ability to do a task. So far WBAs are the only available assessment tools...
2.
Kalsi J, Arya M, Freeman A, Minhas S, Ralph D
Scand J Urol Nephrol
. 2004 Jun;
38(1):92-3.
PMID: 15204436
We describe a case of pilonidal sinus on the penis which presented with erectile dysfunction.
3.
Kalsi J, Kell P
J Eur Acad Dermatol Venereol
. 2004 Apr;
18(3):267-74.
PMID: 15096134
Impairment of erectile function compromises quality of life in millions of men and their partners, many of whom prefer to suffer in silence. It is important to maintain an elevated...
4.
Kalsi J, Kell P, Cellek S, Ralph D
Int J Impot Res
. 2004 Feb;
16(2):195-200.
PMID: 14961060
Phosphodiesterase type 5 (PDE5) inhibitors have reduced efficacy in treating erectile dysfunction (ED) in conditions where there is a lack of endogenous nitric oxide (NO). Therefore, NO-releasing PDE5 inhibitors have...
5.
Kalsi J, Bahadur G, Muneer A, Ozturk O, Christopher N, Ralph D, et al.
Reprod Biomed Online
. 2003 Dec;
7(4):456-61.
PMID: 14656408
Erectile dysfunction (ED) affects the lives of approximately 150 million men worldwide. ED may be a cause of male sub-fertility in a significant proportion of patients. There is now an...
6.
Minhas S, Kalsi J, Ralph D
Hosp Med
. 2003 Oct;
64(10):589-92.
PMID: 14584238
Oral phosphodiesterase inhibitors have become the mainstay of treatment for erectile dysfunction. A novel and potent phosphodiesterase inhibitor, tadalafil, known as Cialis, has been introduced in the UK as an...
7.
Kalsi J, Minhas S, Kell P, Ralph D
Hosp Med
. 2003 Jun;
64(5):292-5.
PMID: 12789739
Erectile dysfunction is a common disease affecting the lives of millions of men worldwide. Sildenafil was the first oral treatment licensed for male erectile dysfunction. However, there are now a...
8.
Kalsi J, Minhas S, Arya M, Peters J, Venn S, Woodhouse C
BJU Int
. 2002 Dec;
90(9):968-9.
PMID: 12460366
No abstract available.
9.
Kalsi J, Cellek S, Muneer A, Kell P, Ralph D, Minhas S
Expert Opin Pharmacother
. 2002 Nov;
3(11):1613-29.
PMID: 12437495
Erectile dysfunction (ED) is defined as the inability to achieve and maintain a penile erection adequate for satisfactory sexual intercourse. It is a significant male health problem of global dimensions...
10.
Kalsi J, Arya M, Minhas S, Ralph D
Hosp Med
. 2002 May;
63(4):224-5.
PMID: 11995273
Priapism is defined as a prolonged penile erection that fails to subside despite orgasm. It is a medical emergency which should be diagnosed and treated early to preserve erectile function...